Toshifumi Kimura

Title: The Innovations of Toshifumi Kimura

Introduction

Toshifumi Kimura is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various brain disorders. With a total of 7 patents to his name, Kimura's work has the potential to impact the treatment of several mental and physical health conditions.

Latest Patents

Among his latest patents, Kimura has developed 1,4-substituted piperazine derivatives. This compound is represented by the formula (I) or a pharmaceutically acceptable salt thereof. It exhibits a metabotropic glutamate receptor 1 inhibitory effect, making it useful for treating brain disorders such as convulsions, acute pain, inflammatory pain, chronic pain, cerebral infarction, or transient cerebral ischemic attacks. Additionally, it addresses mental dysfunctions like schizophrenia and diseases such as anxiety and drug addiction. Another significant invention is the diaryl-substituted five-membered heterocycle derivative, which provides compounds represented by formula (I) or pharmaceutical salts thereof.

Career Highlights

Throughout his career, Kimura has worked with prominent companies in the pharmaceutical industry, including Banyu Pharmaceutical Co. Ltd and MSD K.K. His experience in these organizations has allowed him to refine his skills and contribute to innovative solutions in medicine.

Collaborations

Kimura has collaborated with several talented individuals in his field, including Norikazu Otake and Toru Fujikawa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Toshifumi Kimura's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through scientific research. His patents reflect a deep understanding of complex medical issues and a dedication to finding effective treatments.